Non-cell-autonomous activation of IL-6/STAT3 signaling mediates FGF19-driven hepatocarcinogenesis

Mei Zhou(NGM Biopharmaceuticals (United States)), Lei Ling(NGM Biopharmaceuticals (United States))
Nature Communications
May 16, 2017
Cited by 123


Related Papers